why choose us

First received: January 04, 2023

Clinical Trial: Probability of Optimal Target Attainment of Amikacin in Patients With Febrile Neutropenia During Treatment for a Hematological Disorder

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Febrile Neutropenia (FN)

Study Type: OBSERVATIONAL


Official Title: Probability of Optimal Target Attainment of Amikacin in Patients With Febrile Neutropenia During Treatment for a Hematological Disorder: a Prospective, Single-centre Study and PKPD-analysis

Brief Summary: The present trial is a single center, prospective, observational pharmacokinetics and pharmacodynamics (PKPD) cohort study investigating whether patients suffering from a hematological disorder and treated with amikacin due to febrile neutropenia (FN) achieve the predefined amikacin target concentration (Cmax ?60 mg/L).

Read more